WM
RGNX icon

WS Management’s Regenxbio RGNX Stock Holding History

WS Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-100,000
Closed -$5.14M – 74
2019
Q2 		$5.14M Buy
100,000
+64,400
+181% +$3.22M 0.33% 49
2019
Q1 		$2.04M Buy
35,600
+11,800
+50% +$585K 0.12% 56
2018
Q4 		$998K Buy
+23,800
New +$1.4M 0.05% 76
2018
Q3 		– Sell
-50,000
Closed -$3.59M – 84
2018
Q2 		$3.59M Buy
+50,000
New +$2.39M 0.1% 67

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WS Management's RGNX Position: Q4 2024 in Review

WS Management sold out of Regenxbio (RGNX) in Q4 2024, closing a stake of 300,000 shares — an estimated $3.15M sold.

WS Management first reported a position in RGNX in Q1 2018 and held it in 27 quarters. The position peaked at $74.5M in Q2 2018. 177 funds tracked by Wall St. Rank hold RGNX as of Q4 2024.

  • WS Management reported no remaining Regenxbio position as of Q4 2024 after selling out during the quarter.
  • WS Management sold 300,000 Regenxbio shares in Q4 2024, an estimated $3.15M.
  • WS Management first reported a position in Regenxbio in Q1 2018 and held it in 27 quarters.
  • WS Management's Regenxbio position peaked at $74.5M in Q2 2018.
  • 177 funds tracked by Wall St. Rank held Regenxbio as of Q4 2024.

Based on WS Management's 13F filing for Q4 2024, filed 14 Feb 2025.